A citation-based method for searching scientific literature

Carol A Townsley, Rita Selby, Lillian L Siu. J Clin Oncol 2005
Times Cited: 397







List of co-cited articles
450 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Vivek H Murthy, Harlan M Krumholz, Cary P Gross. JAMA 2004
23

Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
L F Hutchins, J M Unger, J J Crowley, C A Coltman, K S Albain. N Engl J Med 1999
21

Participation of patients 65 years of age or older in cancer clinical trials.
Joy H Lewis, Meredith L Kilgore, Dana P Goldman, Edward L Trimble, Richard Kaplan, Michael J Montello, Michael G Housman, José J Escarce. J Clin Oncol 2003
752
21

Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations.
Arti Hurria, William Dale, Margaret Mooney, Julia H Rowland, Karla V Ballman, Harvey J Cohen, Hyman B Muss, Richard L Schilsky, Betty Ferrell, Martine Extermann,[...]. J Clin Oncol 2014
200
13

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, Gwynn Ison, Nancy U Lin, Lia Gore, Thomas S Uldrick, Stuart M Lichtman, Nancy Roach, Julia A Beaver,[...]. J Clin Oncol 2017
224
12


Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
Carol A Townsley, Kelvin K Chan, Gregory R Pond, Christine Marquez, Lillian L Siu, Sharon E Straus. BMC Cancer 2006
92
11

Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.
Arti Hurria, Laura A Levit, William Dale, Supriya G Mohile, Hyman B Muss, Louis Fehrenbacher, Allison Magnuson, Stuart M Lichtman, Suanna S Bruinooge, Enrique Soto-Perez-de-Celis,[...]. J Clin Oncol 2015
231
11

Barriers to clinical trial participation by older women with breast cancer.
M Margaret Kemeny, Bercedis L Peterson, Alice B Kornblith, Hyman B Muss, Judith Wheeler, Ellis Levine, Nancy Bartlett, Gini Fleming, Harvey J Cohen. J Clin Oncol 2003
278
11

Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.
Jean G Ford, Mollie W Howerton, Gabriel Y Lai, Tiffany L Gary, Shari Bolen, M Chris Gibbons, Jon Tilburt, Charles Baffi, Teerath Peter Tanpitukpongse, Renee F Wilson,[...]. Cancer 2008
603
11

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
P N Lara, R Higdon, N Lim, K Kwan, M Tanaka, D H Lau, T Wun, J Welborn, F J Meyers, S Christensen,[...]. J Clin Oncol 2001
442
10

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group.
Stuart M Lichtman, R Donald Harvey, Marie-Anne Damiette Smit, Atiqur Rahman, Michael A Thompson, Nancy Roach, Caroline Schenkel, Suanna S Bruinooge, Patricia Cortazar, Dana Walker,[...]. J Clin Oncol 2017
87
11

The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.
Joseph M Unger, Elise Cook, Eric Tai, Archie Bleyer. Am Soc Clin Oncol Educ Book 2016
214
10

A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
Sara H Javid, Joseph M Unger, Julie R Gralow, Carol M Moinpour, Antoinette J Wozniak, J Wendall Goodwin, Primo N Lara, Pamela A Williams, Laura F Hutchins, Carolyn C Gotay,[...]. Oncologist 2012
69
13

Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score.
Martine Extermann, Ivette Boler, Richard R Reich, Gary H Lyman, Richard H Brown, Joseph DeFelice, Richard M Levine, Eric T Lubiner, Pablo Reyes, Frederic J Schreiber,[...]. Cancer 2012
632
8


Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
8

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.
Supriya G Mohile, William Dale, Mark R Somerfield, Mara A Schonberg, Cynthia M Boyd, Peggy S Burhenn, Beverly Canin, Harvey Jay Cohen, Holly M Holmes, Judith O Hopkins,[...]. J Clin Oncol 2018
485
8

Barriers to participation in randomised controlled trials: a systematic review.
S Ross, A Grant, C Counsell, W Gillespie, I Russell, R Prescott. J Clin Epidemiol 1999
646
7

Future of cancer incidence in the United States: burdens upon an aging, changing nation.
Benjamin D Smith, Grace L Smith, Arti Hurria, Gabriel N Hortobagyi, Thomas A Buchholz. J Clin Oncol 2009
7

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
7


Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change.
Angelica P Herrera, Shedra Amy Snipes, Denae W King, Isabel Torres-Vigil, Daniel S Goldberg, Armin D Weinberg. Am J Public Health 2010
145
6




Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer.
Arti Hurria, Supriya Mohile, Ajeet Gajra, Heidi Klepin, Hyman Muss, Andrew Chapman, Tao Feng, David Smith, Can-Lan Sun, Nienke De Glas,[...]. J Clin Oncol 2016
316
6

Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?
Karen W L Yee, Joseph L Pater, Lam Pho, Benny Zee, Lillian L Siu. J Clin Oncol 2003
236
6

Expanding the Evidence Base in Geriatric Oncology: Action Items From an FDA-ASCO Workshop.
Laura A Levit, Harpreet Singh, Heidi D Klepin, Arti Hurria. J Natl Cancer Inst 2018
41
14


International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
Hans Wildiers, Pieter Heeren, Martine Puts, Eva Topinkova, Maryska L G Janssen-Heijnen, Martine Extermann, Claire Falandry, Andrew Artz, Etienne Brain, Giuseppe Colloca,[...]. J Clin Oncol 2014
867
5

Prognostic importance of comorbidity in a hospital-based cancer registry.
Jay F Piccirillo, Ryan M Tierney, Irene Costas, Lori Grove, Edward L Spitznagel. JAMA 2004
844
5

Public attitudes toward participation in cancer clinical trials.
Robert L Comis, Jon D Miller, Carolyn R Aldigé, Linda Krebs, Ellen Stoval. J Clin Oncol 2003
268
5


Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.
Arti Hurria, Kayo Togawa, Supriya G Mohile, Cynthia Owusu, Heidi D Klepin, Cary P Gross, Stuart M Lichtman, Ajeet Gajra, Smita Bhatia, Vani Katheria,[...]. J Clin Oncol 2011
998
5

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.
Matthew T Seymour, Lindsay C Thompson, Harpreet S Wasan, Gary Middleton, Alison E Brewster, Stephen F Shepherd, M Sinead O'Mahony, Timothy S Maughan, Mahesh Parmar, Ruth E Langley. Lancet 2011
233
5

Comparison of survival outcomes among cancer patients treated in and out of clinical trials.
Joseph M Unger, William E Barlow, Diane P Martin, Scott D Ramsey, Michael Leblanc, Ruth Etzioni, Dawn L Hershman. J Natl Cancer Inst 2014
138
5

Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
Alice B Kornblith, Margaret Kemeny, Bercedis L Peterson, Judith Wheeler, Jeffrey Crawford, Nancy Bartlett, Gini Fleming, Stephen Graziano, Hyman Muss, Harvey Jay Cohen. Cancer 2002
137
5

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
Warren B Sateren, Edward L Trimble, Jeffrey Abrams, Otis Brawley, Nancy Breen, Leslie Ford, Mary McCabe, Richard Kaplan, Malcolm Smith, Richard Ungerleider,[...]. J Clin Oncol 2002
388
5

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma.
Allison S Betof, Ryan D Nipp, Anita Giobbie-Hurder, Romany A N Johnpulle, Krista Rubin, Samuel M Rubinstein, Keith T Flaherty, Donald P Lawrence, Douglas B Johnson, Ryan J Sullivan. Oncologist 2017
94
5

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).
Laura Biganzoli, Hans Wildiers, Catherine Oakman, Lorenza Marotti, Sibylle Loibl, Ian Kunkler, Malcolm Reed, Stefano Ciatto, Adri C Voogd, Etienne Brain,[...]. Lancet Oncol 2012
361
5

Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
Mara A Schonberg, Edward R Marcantonio, Donglin Li, Rebecca A Silliman, Long Ngo, Ellen P McCarthy. J Clin Oncol 2010
272
5

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado,[...]. N Engl J Med 2015
5

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
5


New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
5

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
5

Screening older cancer patients: first evaluation of the G-8 geriatric screening tool.
C A Bellera, M Rainfray, S Mathoulin-Pélissier, C Mertens, F Delva, M Fonck, P L Soubeyran. Ann Oncol 2012
372
5

Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
Ethan B Ludmir, Walker Mainwaring, Timothy A Lin, Austin B Miller, Amit Jethanandani, Andres F Espinoza, Jacob J Mandel, Steven H Lin, Benjamin D Smith, Grace L Smith,[...]. JAMA Oncol 2019
81
6

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.